cancer

Expert Discusses Pulmonary Nodules and Lung Cancer Screening

by

OSUWexnerbloglogo2014 Expert Discusses Pulmonary Nodules and Lung Cancer Screening. Today on MedNet21, we are going to help you use the chest CT in your own clinical practice in order to save lives. My guest is pulmonologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Mike Wert.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: develop an evidence-based approach to the management of solitary pulmonary nodules; and understand the evidence behind and the importance of lung cancer screening in high-risk patients.

You’ll also learn about the following:

  • Efficacy of lung cancer screening
  • Challenges with lung cancer screening?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Management of Cancer Pain in the Ambulatory Setting

by

OSUWexnerbloglogo2014 Learn About Management of Cancer Pain in the Ambulatory Setting. The most common cancers in the U.S. are colorectal, lung, prostate, and breast cancer. The good news is that cancer deaths are declining. But this means that more people are living with cancer or living as cancer survivors than ever before and many of these people can have pain. The primary care physician is often the first line of treatment of patients with cancer pain. And that brings up questions such as “When should I prescribe opioids?” and “What non-opioid treatments might help my patient?”. On this CME webcast, we are going to give you the tools you need to manage patients with cancer pain. Let me welcome today’s guest. Dr. Sachin Kale is an Assistant Professor from the Division of Palliative Medicine at the Ohio State University.

What you’ll learn in this webcast

As  a result of this educational activity, webcast participants will be able to: DESCRIBE a multimodal approach to treating cancer pain that is based on where a patient is on his/her cancer trajectory; and DESCRIBE a Universal Precautions approach to prescribing opioids.

You’ll also learn about the following:

  • Cancer pain strategies and hospice
  • Post-mastectomy pain syndrome
  • The role of radiation therapy
  • The role of massage and acupuncture
  • When to refer to palliative medicine
  • When to refer to pain management

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Physicians About Skin Cancer

by

OSUWexnerbloglogo2014 CME Webcast Teaches Physicians About Skin Cancer. In the 215 years since Laennec discovered melanoma, we have learned an enormous amount about this malignancy and how to best treat it. On this CME webcast, we’re going to update you on the latest information. Joining our moderator are two skin cancer specialists from the James Cancer Hospital. Dr. Joal Beane is a surgical oncologist and Assistant Professor of Surgery at the Ohio State University. And Dr. Carlo Contreras is an Associate Professor of Surgery, also from the OSU Division of Surgical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Describe at least two advantages of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; List the 2 main classes of neoadjuvant therapy in patients with resectable Stage III/IV melanoma; and UNDERSTAND the diagnosis and management of cutaneous melanoma.

You’ll also learn about the following:

  • Subtypes of melanoma
  • Evaluation and diagnosis
  • Indications for referral
  • Role of metastasectomy in advanced melanoma

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Educates Learners on Lung Cancer Staging

by

OSUWexnerbloglogo2014 CME Webcast Educates Learners on Lung Cancer Staging. On this program, we’re going to update you on the approach to lung cancer staging. Joining on moderator is our lung cancer expert from the Division of Hematology and Medical Oncology, Clinical Instructor of Internal Medicine, Dr. Jean Bustamante Alvarez.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of lung cancer staging and the need for a multidisciplinary approach; and IDENTIFY the minimally necessary studies that will be necessary to stage a patient with lung cancer.

You’ll also learn about the following:

  • Racial disparities in lung cancer diagnosis and survival
  • Staging small cell lung cancer
  • Surgery versus stereotactic ablative radiotherapy
  • Stereotactic ablative radiotherapy
  • When PET-CT can miss lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Webcast Teaches on Prostate Cancer Screening

by

OSUWexnerbloglogo2014 On-line CME Webcast Teaches on Prostate Cancer Screening. On this CME webcast, we’ll be examining the conundrum of prostate cancer screening. Joining our moderator in the studio is urologic oncologist and Assistant Professor of Urology, Dr. Shawn Dason.

 

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the rationale, benefits, and harms of prostate cancer screening; and DEVELOP an approach for prostate cancer screening in a primary care setting.

You’ll also learn about the following:

  • Prostate cancer risk factors
  • The problem with the PSA
  • False positive PSAs
  • False negative PSAs
  • Interpreting the PSA trajectory over time
  • The urologist’s approach to an elevated PSA
  • Common prostate cancer treatments and their complications

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.